المؤلفون: Ala Abudayyeh, Cassian Yee, Nizar M. Tannir, Maria E. Suarez-Almazor, Shana Machado, Biruh Workeneh, Sheldon Chen, Amanda Tchakarov, Umut Selamet, Lillian W. Gaber, Huifang Lu, William F Glass, Amit Lahoti, Omar Mamlouk, Jamie S. Lin, Noha Abdel-Wahab, Maen Abdelrahim, Jean Tayar, Adi Diab

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, C3 Glomerulonephritis, Biopsy, medicine.medical_treatment, Gastroenterology, Antineoplastic Agents, Immunological, 0302 clinical medicine, Glomerulonephritis, Neoplasms, Immunology and Allergy, Molecular Targeted Therapy, medicine.diagnostic_test, Acute tubulointerstitial nephritis, Acute kidney injury, Immunosuppression, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Renal biopsy, Immunotherapy, Checkpoint inhibitors, Adult, medicine.medical_specialty, Immunology, Short Report, lcsh:RC254-282, Nephropathy, Immunomodulation, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, Pharmacology, business.industry, medicine.disease, 030104 developmental biology, Nephritis, Interstitial, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f58900cac8f0bce3b3f93210ae60e315Test
http://link.springer.com/article/10.1186/s40425-018-0478-8Test

المؤلفون: Noha Abdel-Wahab, Adi Diab, Hiroyuki Katayama, Maria E. Suarez-Almazor, Samir M. Hanash, Sang Kim

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Cancer, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Blood proteins, lcsh:RC254-282, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Immune system, chemistry, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, medicine, Biomarker (medicine), business, Adverse effect, 030215 immunology, Pneumonitis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b2a9c67abdc9249bef2d3e070d5d96Test
https://doaj.org/article/6ea874c677f141c29847bbd9b9f96a20Test

المؤلفون: Robin Christensen, Annette Schlemmer, Ellen-Margrethe Hauge, Line Uhrenholt, Salome Kristensen, Lene Dreyer, Maria E. Suarez-Almazor

المصدر: BMJ Open
Uhrenholt, L, Schlemmer, A, Hauge, E-M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517, pp. 1-11 . https://doi.org/10.1136/bmjopen-2018-028517Test
Uhrenholt, L, Schlemmer, A, Hauge, E M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : Protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517 . https://doi.org/10.1136/bmjopen-2018-028517Test
Uhrenholt, L, Schlemmer, A, Hauge, E-M, Christensen, R, Dreyer, L, Suarez-Almazor, M E & Kristensen, S 2019, ' Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis : protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial) ', BMJ Open, vol. 9, no. 7, e028517 . https://doi.org/10.1136/bmjopen-2018-028517Test

مصطلحات موضوعية: rheumatoid arthritis, medicine.medical_specialty, tapering, Disease, law.invention, Arthritis, Rheumatoid, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Stable Disease, Deprescriptions, Randomized controlled trial, Rheumatology, law, Internal medicine, medicine, Protocol, Humans, Spondylitis, Ankylosing, 030212 general & internal medicine, Axial spondyloarthritis, 030203 arthritis & rheumatology, Protocol (science), psoriatic arthritis, Biological Products, Dose-Response Relationship, Drug, business.industry, Arthritis, Psoriatic, axial spondyloarthritis, General Medicine, medicine.disease, Discontinuation, biological therapy, Rheumatoid arthritis, Antirheumatic Agents, Spondylarthropathies, business, dosage reduction

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac858e0ca0bbb6ce1563a184c545a3d8Test
http://europepmc.org/articles/PMC6624054Test